Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
Open accessThe DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.
Abstract
Elucidating the signalling mechanisms by which obesity leads to impaired insulin action is critical in the development of therapeutic strategies for the treatment of diabetes. Recently, mice deficient for S6 Kinase 1 (S6K1), an effector of the mammalian target of rapamycin (mTOR) that acts to integrate nutrient and insulin signals, were shown to be hypoinsulinaemic, glucose intolerant and have reduced beta-cell mass. However, S6K1-deficient mice maintain normal glucose levels during fasting, suggesting hypersensitivity to insulin, raising the question of their metabolic fate as a function of age and diet. Here, we report that S6K1-deficient mice are protected against obesity owing to enhanced beta-oxidation. However on a high fat diet, levels of glucose and free fatty acids still rise in S6K1-deficient mice, resulting in insulin receptor desensitization. Nevertheless, S6K1-deficient mice remain sensitive to insulin owing to the apparent loss of a negative feedback loop from S6K1 to insulin receptor substrate 1 (IRS1), which blunts S307 and S636/S639 phosphorylation; sites involved in insulin resistance. Moreover, wild-type mice on a high fat diet as well as K/K A(y) and ob/ob (also known as Lep/Lep) mice-two genetic models of obesity-have markedly elevated S6K1 activity and, unlike S6K1-deficient mice, increased phosphorylation of IRS1 S307 and S636/S639. Thus under conditions of nutrient satiation S6K1 negatively regulates insulin signalling.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We discuss how pathways that “sense” nutrients within skeletal muscle are readily able to regulate insulin action.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [37]
In the citing paper
“The mTOR/ p70S6 kinase pathway is a putative nutrient-sensing pathway, and overactivation of this pathway in cell-based systems, rodents, and humans is also associated with insulin resistance (37)(38)(39).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [37]
In the citing paper
“Obese and type 2 diabetic rodents have increased mTOR/S6K signaling and this may contribute to insulin resistance [151-153].”
From AMPK and Exercise: Glucose Uptake and Insulin Sensitivity (2013) · cites this paper as [151]
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419 · cited 1×
“To test this further, two genetic models of obesity were examined: K/K A y and ob/ob mic”
MethodMootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · cited 1×
“gif" NDATA ITEM> ]> Elucidating the signalling mechanisms by which obesity leads to impaired insulin action is critical in the development of therapeutic strategies for the treatment of diabete”
BackgroundA central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · cited 1×
“Protein extracts from tissue samples were analysed as describe”
MethodObesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728 · cited 1×
“As increased circulating FFAs are implicated in insulin resistanc”
BackgroundHara, K., Yonezawa, K., Weng, Q.-P., Kozlowski, M. T., Belham, C., & Avruch, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14484 · Cited by 1,367
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
Fingar, D. C., Salama, S., Tsou, C., Harlow, E., & Blenis, J. (2002) · Genes & Development · doi:10.1101/gad.995802 · Cited by 1,093 · cited 4×
“a, S6K1 Thr 389 and S6 Ser 240/244 phosphorylation in fat of wild-type mice maintained on a NCD (2) or HFD (þ) for 4 months.”
BackgroundMethodInfluential
Cited by
Items 701–800 of 1,004
Polonsky, K. S., & Burant, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00031-9 · Cited by 77
Prabhu, S., Saadat, D., Zhang, M., Halbur, L., Fruehauf, J. P., & Ong, S. T. (2006) · Oncogene · doi:10.1038/sj.onc.1209901 · Cited by 55
“mTOR performs these functions by promoting protein synthesis, metabolism, transcription and ribosome biogenesis (Jacinto and Hall, 2003; Um et al., 2004; Wullschleger et al., 2006).”
BackgroundNCI's provocative questions on cancer: some answers to ignite discussion
Blagosklonny, M. V. (2011) · Oncotarget · doi:10.18632/oncotarget.432 · Cited by 54
Islam, T., Albracht-Schulte, K., Ramalingam, L., Schlabritz-Lutsevich, N., Park, O.-H., Zabet-Moghaddam, M., Kalupahana, N. S., & Moustaid-Moussa, N. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109242 · Cited by 48
Rheb and mammalian target of rapamycin in mitochondrial homoeostasis
Groenewoud, M. J., & Zwartkruis, F. J. T. (2013) · Open Biology · doi:10.1098/rsob.130185 · Cited by 60
“whole body S6K1 deletion increased mitochondrial content skeletal muscle [62]”
BackgroundWatanabe, R., Tambe, Y., Inoue, H., Isono, T., Haneda, M., Isobe, K., Kobayashi, T., Hino, O., Okabe, H., & Chano, T. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.19.3.475 · Cited by 52
Effect of mTOR inhibitor on body weight: from an experimental rat model to human transplant patients
Rovira, J., Marcelo Arellano, E., Burke, J. T., Brault, Y., Moya-Rull, D., Bañón-Maneus, E., Ramírez-Bajo, M. J., Gutiérrez-Dalmau, A., Revuelta, I., Quintana, L. F., et al. (2008) · Transplant International · doi:10.1111/j.1432-2277.2008.00710.x · Cited by 52
“Besides, the S6K1)/) genotype protects from obesity induced by nutrients [13].”
BackgroundXia, T., Cheng, Y., Zhang, Q., Xiao, F., Liu, B., Chen, S., & Guo, F. (2012) · Diabetes · doi:10.2337/db11-1278 · Cited by 53
“Recent studies have demonstrated a key role for S6K1 signaling in the regulation of energy homeostasis in Drosophila (6), in mice deficient in S6K1 (7,8), and in rats injected with S6K1 expression vector in the mediobasal hypothalamus (9).”
BackgroundResultInfluentialmTOR: more targets of resveratrol?
Widlund, A. L., Baur, J. A., & Vang, O. (2013) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2013.11 · Cited by 52
Prizant, R. L., & Barash, I. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21904 · Cited by 54
“AA-activated signaling towards protein translation through mTOR has been studied in various tissues and cell lines, including adipose tissue [Lynch et al., 2002; Um et al., 2004; Zhang et al., 2007], liver [Reiter et al.”
BackgroundInfluentialEmerging Roles of Cellular Metabolism in Regulating Dendritic Cell Subsets and Function
Du, X., Chapman, N. M., & Chi, H. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00152 · Cited by 57
“Of note, mTORC1 antagonizes FAO in other systems (Um et al., 2004; Soliman, 2011), suggesting that IFNAR signaling may modulate mTORC1 activation to enforce FAO in TLR9stimulated pDCs.”
BackgroundThe mTOR pathway: Implications for DNA replication
Lamm, N., Rogers, S., & Cesare, A. J. (2019) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2019.04.002 · Cited by 54
Kaeberlein, M., & Kennedy, B. K. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00341.x · Cited by 51
“…that decrease S6K activity increase lifespan in both worms and flies (Kapahi et al. , 2004; Pan et al. , 2007), and S6K1 knockout mice have intriguing phenotypes, including resistance to ageand diet-induced obesity (Um et al. , 2004), although the longevity of these mice has not been reported.”
BackgroundDual roles of mTORC1-dependent activation of the ubiquitin-proteasome system in muscle proteostasis
Kaiser, M. S., Milan, G., Ham, D. J., Lin, S., Oliveri, F., Chojnowska, K., Tintignac, L. A. J., Mittal, N., Zimmerli, C. E., Glass, D. J., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-04097-y · Cited by 54
“A similar phenomenon appears to occur as a result of mTORC1-driven UPS induction, since (1) PKB/Akt-activation drives rapid muscle hypertrophy in TSCmKO mice and (2) the slow-twitch soleus muscle, which fails to induce E3 ligase gene expression (e.”
BackgroundBarbour, L. A., McCurdy, C. E., Hernandez, T. L., & Friedman, J. E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2116 · Cited by 47
Mechanistic target of rapamycin controls homeostasis of adipogenesis
Yoon, M., Zhang, C., Sun, Y., Schoenherr, C. J., & Chen, J. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m037705 · Cited by 56
Ginsenoside Rg1 inhibits angiotensin II‐induced podocyte autophagy via AMPK/mTOR/PI3K pathway
Mao, N., Tan, R., Wang, S., Wei, C., Shi, X., Fan, J., & Wang, L. (2016) · Cell Biology International · doi:10.1002/cbin.10634 · Cited by 50
“, 1995), P70S6K was reported to inhibit autophagy, whichmay through a negative feedback to inhibits activation of phosphatidylinositol-3OH kinase(PI3K) class I (Um et al., 2004).”
BackgroundDEPDC5 as a potential therapeutic target for epilepsy
Myers, K. A., & Scheffer, I. E. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1316715 · Cited by 51
“protein synthesis [36–38], though S6K1 also has a role in regulation of lipid synthesis [39].”
BackgroundEffects of vaspin on pancreatic β cell secretion via PI3K/Akt and NF-κB signaling pathways
Liu, S., Li, X., Wu, Y., Duan, R., Zhang, J., Du, F., Zhang, Q., Li, Y., & Li, N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189722 · Cited by 55
mTOR: A double-edged sword for diabetes
Tuo, Y., & Xiang, M. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0317-095rr · Cited by 53
Chen, C., Liao, Y., Tsai, S.-C., & Thompson, L. V. (2019) · GeroScience · doi:10.1007/s11357-019-00109-8 · Cited by 53
“S6K phosphorylates insulin receptor substrate 1, which in turn inhibits the insulin signaling pathway (Tremblay et al. 2005; Um et al. 2004, 2006; Zhang et al. 2008).”
BackgroundIntegrated Pathways of COX-2 and mTOR: Roles in Cell Sensing and Alzheimer’s Disease
Tyagi, A., Kamal, M. A., & Poddar, N. K. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00693 · Cited by 53
“…| Article 693 that mTORC1 is inhibitory for thermogenesis and “browning effect” (conversion of white adipose tissue to brown/beige adipocytes), which help tackle obesity by inducing enhanced energy consumption processes (M. Um et al., 2004; Polak et al., 2008; Liu et al., 2014; Wada et al., 2016).”
BackgroundPeng, Y., Guo, L., Gu, A., Shi, B., Ren, Y.-K., Cong, J., & Yang, X. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00198-8 · Cited by 53
Müssig, K., Fiedler, H., Staiger, H., Weigert, C., Lehmann, R., Schleicher, E. D., & Häring, H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.154 · Cited by 55
Duchêne, S., Métayer, S., Cailleau-Audouin, E., Bigot, K., Dupont, J., & Tesseraud, S. (2006) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2006.09.002 · Cited by 54
McNeill, H., Craig, G. M., & Bateman, J. E. (2008) · Genetics · doi:10.1534/genetics.107.083097 · Cited by 55
“Recently a negative feedback loop in which S6K regulates IRS, both transcriptionally and by phosphorylation, has been shown to exist in both Drosophila (Radimerski et al. 2002) and mammalian systems (Harrington et al. 2004; Shah et al. 2004; Um et al. 2004).”
BackgroundBae, E. J., Yang, Y. M., Kim, J. W., & Kim, S. G. (2007) · Hepatology · doi:10.1002/hep.21769 · Cited by 50
Lang, S. A., Hackl, C., Moser, C., Fichtner‐Feigl, S., Koehl, G. E., Schlitt, H. J., Geissler, E. K., & Stoeltzing, O. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.01.009 · Cited by 52
“Since the IGF-IR/IRS-1 signaling axis has recently been identified to be involved in the feedback mechanism of mTOR-inhibitormediated Akt activation in cancer cells [28,29], we sought to further define the impact of mTOR blockade on IGF-IR function per se, as this has not been fully elucidated to date.”
BackgroundInfluentialHuang, C., Pang, D., Luo, Q., Chen, X., Gao, Q., Shi, L., Liu, W., Zou, Y., Li, L., & Chen, Z. (2016) · Molecules · doi:10.3390/molecules21050586 · Cited by 49
ZRF1 is a novel S6 kinase substrate that drives the senescence programme
Barilari, M., Bonfils, G., Treins, C., Koka, V., Villeneuve, D. D., Fabrega, S., & Pende, M. (2017) · The EMBO Journal · doi:10.15252/embj.201694966 · Cited by 55
“As expected, Akt phosphorylation inversely correlated with S6K activity, due to the negative feedback loop of mTORC1/S6K on mTORC2/Akt (Um et al , 2004; Hsu et al , 2011; Yu et al , 2011).”
Veiga, S. R., Ge, X., Mercer, C. A., Hernández‐Álvarez, M. I., Thomas, H. E., Hernández‐Losa, J., y Cajal, S. R., Zorzano, A., Thomas, G., & Kozma, S. C. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0177 · Cited by 50
“Despite being a very heterogeneous tumor type without clear genetic drivers, the most aggressive formsofHCCare associatedwith the TGFb1, PI3K/Akt/ mTOR,Wnt/b-catenin, andNOTCHproliferative pathways (4, 5).”
BackgroundSelf-citationRole of Phosphatidylinositol 3,4,5-Trisphosphate in Cell Signaling
Riehle, R. D., Cornea, S., & Degterev, A. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-6331-9_7 · Cited by 58
Molecular Mechanisms of Insulin Resistance Development
Va, T., & Vorotnikov, A. V. (2014) · Diabetes Mellitus · doi:10.14341/dm2014229-40 · Cited by 54
The Impact of Overnutrition on Insulin Metabolic Signaling in the Heart and the Kidney
Pulakat, L., DeMarco, V. G., Whaley‐Connell, A. T., & Sowers, J. R. (2011) · Cardiorenal Medicine · doi:10.1159/000327140 · Cited by 51
“There is emerging evidence that overnutrition, aldosterone and angiotensin (ANG) II may promote INS resistance through the mammalian target of rapamycin (mTOR)/S6 kinase 1 (S6K1) signaling pathway. The mTOR molecule, a highly conserved nutrient sensor, modulates INS metabolic signaling through its phosphorylation [(P)…”
BackgroundYaspelkis, B. B., Kvasha, I. A., & Figueroa, T. Y. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00117.2009 · Cited by 47
André, C., & Cota, D. (2012) · Proceedings of The Nutrition Society · doi:10.1017/s0029665112000754 · Cited by 52
“Interestingly, mice lacking S6K1 and therefore characterised by a defective mTORC1 signalling, have reduced adipose tissue mass and are resistant to diet-induced obesity((29)).”
BackgroundEndo, H., Hosono, K., Fujisawa, T., Takahashi, H., Sugiyama, M., Yoneda, K., Nozaki, Y., Fujita, K., Yoneda, M., Inamori, M., et al. (2009) · Gut · doi:10.1136/gut.2009.183624 · Cited by 49
“Recently, the mTOR/S6K pathway, which is similar to the JNK pathway, has emerged as a critical signalling pathway in the development of insulin resistance.”
BackgroundDeficiency in mTORC1‐controlled C/EBPβ‐mRNA translation improves metabolic health in mice
Zidek, L. M., Ackermann, T., Hartleben, G., Eichwald, S., Kortman, G., Kiehntopf, M., Leutz, A., Sonenberg, N., Wang, Z., von Maltzahn, J., et al. (2015) · EMBO Reports · doi:10.15252/embr.201439837 · Cited by 50
mTOR activation protects liver from ischemia/reperfusion‐induced injury through NF‐κB pathway
Li, Z., Zhang, J., Mulholland, M. T., & Zhang, W. (2017) · The FASEB Journal · doi:10.1096/fj.201601278r · Cited by 48
“Absence of S6 kinase 1, the mTOR downstream target, protects against dietinduced obesity and improves insulin sensitivity in mice (7).”
BackgroundTargeting the mTOR Pathway Using Deforolimus in Cancer Therapy
Mahalingam, D., Sankhala, K. K., Mita, A. C., Giles, F. J., & Mita, M. M. (2009) · Future Oncology · doi:10.2217/fon.09.9 · Cited by 48
“This feedback loop may have consequences in disorders such as diabetes or obesity, whereby excess nutrients may lead to inappropriate mTOR signaling resulting in a negative feedback loop to attenuate PI3K signaling, which in turn may result in insulin resistance [6,48].”
BackgroundParathath, S. R., Mainwaring, L. A., Fernández-L, A., Campbell, D. O., & Kenney, A. M. (2008) · Development · doi:10.1242/dev.022871 · Cited by 53
“S6K1, a major target of mTOR, is required for IRS1 phosphorylation in cells and can also directly phosphorylate IRS1 (Easton et al., 2006; Um et al., 2004).”
BackgroundLee, N., Choi, H.-K., Shim, J., Kang, K.-W., Dong, Z., & Choi, H. S. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp027 · Cited by 49
Magdalon, J., Chimin, P., Belchior, T., das Neves, R. X., Vieira‐Lara, M. A., Andrade, M. L., Farias, T. S. M., Lopes, A. B., Paschoal, V. A., Yamashita, A. S., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.02.023 · Cited by 52
Potentiation of insulin-stimulated glucose transport by the AMP-activated protein kinase
Ju, J.-S., Gitcho, M. A., Casmaer, C. A., Patil, P. B., Han, D.-G., Spencer, S. A., & Fisher, J. S. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00269.2006 · Cited by 47
Kang, H., You, H. J., Lee, G., Lee, S. H., Yoo, T., Choi, M., Joo, S. K., Park, J. H., Chang, M. S., Lee, D. H., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2078612 · Cited by 49
“Moreover, mTORC1 is highly activated in the liver of diet-induced obese animals with impaired insulin signaling.(44,45) Activation of mTOR is associated with the development of metabolic syndrome and NASH in humans and animals.”
BackgroundDistinct adipose progenitor cells emerging with age drive active adipogenesis
Wang, G., Li, G., Song, A., Zhao, Y., Yu, J., Wang, Y., Dai, W., Salas, M. C., Qin, H., Medrano, L. J., et al. (2025) · Science · doi:10.1126/science.adj0430 · Cited by 57
The Importance of Autophagy in Cardioprotection
Sciarretta, S., Yee, D., Shenoy, V., Nagarajan, N., & Sadoshima, J. (2013) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-013-0029-9 · Cited by 48
PPARγ activation attenuates glucose intolerance induced by mTOR inhibition with rapamycin in rats
Festuccia, W. T., Blanchard, P.-G., Belchior, T., Chimin, P., Paschoal, V. A., Magdalon, J., Hirabara, S. M., Simões, D., St-Pierre, P., Carpinelli, A., et al. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00683.2013 · Cited by 46
“With regards to the latter, there is compelling evidence indicating that obesity-induced mTORC1 overactivation in liver, skeletal muscle, and fat is a crucial event in the development of obesity associated insulin resistance (18, 37, 41).”
BackgroundZhang, Q., Yu, J., Liu, B., Lv, Z., Xia, T., Xiao, F., Chen, S., & Guo, F. (2013) · Diabetes · doi:10.2337/db12-1050 · Cited by 50
“Consistent with a role for S6K1 in insulin sensitivity, S6K1 activity is increased in the livers of db/db mice and in HFD-induced insulin-resistant animal models (34), whereas deletion of S6K1 in mice enhances insulin sensitivity (35,36).”
BackgroundResultLiang, X., Han, J., Xue, M., Yu, H., Huang, H., Wu, X., Zheng, Y., Qin, Y., & Liang, X. (2018) · Aquaculture · doi:10.1016/j.aquaculture.2018.09.010 · Cited by 47
Evans, M. C., Lord, R. A., & Anderson, G. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179210 · Cited by 55
“Mice lacking S6K do not respond to the anorectic actions of leptin [61,62].”
BackgroundImplications of Sphingolipids on Aging and Age-Related Diseases
Li, S., & Kim, H.-E. (2022) · Frontiers in Aging · doi:10.3389/fragi.2021.797320 · Cited by 49
Molero, J. C., Turner, N. A., Thien, C. B. F., Langdon, W. Y., James, D. E., & Cooney, G. J. (2006) · Diabetes · doi:10.2337/db06-0955 · Cited by 49
“These transgenic and knockout animals have been produced by targeting a variety of genes such as UCP1 and UCP3 (32,33); enzymes involved in signaling pathways, including protein-tyrosine phosphatase 1B (PTP-1B) (34) and S6kinase (35); and regulators of transcriptional (PGC-1 , transcriptional intermediary factor-2 [TI…”
BackgroundTranslational Control of Chronic Pain
Melemedjian, O. K., & Khoutorsky, A. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2014.11.006 · Cited by 43
Blazing a trail for the clinical use of rapamycin as a geroprotecTOR
Konopka, A. R., Lamming, D. W., RAP PAC Investigators, Grasso, B. A., Marrah, R. C., Decker, S., Garg, N., Park, Y., Lim, S. Y., Simcox, J., et al. (2023) · GeroScience · doi:10.1007/s11357-023-00935-x · Cited by 50
“Consistent with this model, (1) mice lacking S6K1 , a downstream target of mTOR, are protected from age and diet-induced insulin resistance [29, 31] and (2) rapamycin given intermittently or at a low dose improves metabolic health and insulin sensitivity in mouse models of obesity [32–34].”
MethodEndostatin Prevents Dietary-Induced Obesity by Inhibiting Adipogenesis and Angiogenesis
Wang, H., Chen, Y., Lu, X., Liu, G., Fu, Y., & Luo, Y. (2015) · Diabetes · doi:10.2337/db14-0528 · Cited by 46
“(45) reported that mTORC1 promotes insulin resistance in adipose tissue through the S6K-mediated inhibition of insulin signaling, which is consistent with our finding that endostatin improves insulin resistance and impairs the activity of S6K.”
ResultPaschoal, V. A., Amano, M. T., Belchior, T., Magdalon, J., Chimin, P., Andrade, M. L., Ortiz‐Silva, M., Castro, É., Yamashita, A. S., Neto, J. C. R., et al. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.09.014 · Cited by 48
Zhai, H., Li, Z., Peng, M., Huang, Z., Qin, T., Chen, L., Li, H., Zhang, H., Zhang, W., & Xu, G. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.05.026 · Cited by 47
“Deletion of S6K1 protects against while 4EBP1 gene null worsens glucose metabolism in diet-induced obese mice [28,29] There are two mTOR complexes: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2).”
BackgroundBlanchard, P.-G., Moreira, R. J., Castro, É., Caron, A., Côté, M., Andrade, M. L., Oliveira, T. E., Ortiz‐Silva, M., Peixoto, Á. S., Ruas, F. A. D., et al. (2018) · Metabolism · doi:10.1016/j.metabol.2018.09.007 · Cited by 54
Histone acetyltransferases interact with and acetylate p70 ribosomal S6 kinases in vitro and in vivo
Fenton, T. R., Gwalter, J., Ericsson, J., & Gout, I. T. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.11.022 · Cited by 48
“Pathological conditions including diabetes, tuberous sclerosis and cancer are associated with deregulation of S6K signaling, emphasizing the importance of obtaining a detailed understanding of its regulation and function (Pende et al., 2000; Shamji et al., 2003; Um et al., 2004).”
BackgroundEgawa, T., Tsuda, S., Ma, X., Hamada, T., & Hayashi, T. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00249.2011 · Cited by 48
“Next, to determine whether caffeine might modulate mTOR/p70S6K transduction, which is accompanied by a corresponding increase in IRS-1 phosphorylation of Ser (40, 42), we performed Western blot analysis using an anti-mTOR antibody that recognizes phosphorylated Fig.”
BackgroundMethodResultInfluentialAMPK-associated signaling to bridge the gap between fuel metabolism and hepatocyte viability
Yang, Y. M., Han, C. Y., Kim, Y. J., & Kim, S. G. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i30.3731 · Cited by 50
Sharp, Z. D., & Strong, R. (2010) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glp212 · Cited by 46
“A comparison of the effects of CR on mitochondrial respiration (68) with the phenotype of the S6K1−/− mouse (66) suggests that this genetic model might mimic food restriction in its ability to extend life span and reduce the severity of cancer.”
BackgroundGlynn, E. L., Lujan, H. L., Kramer, V. J., Drummond, M. J., DiCarlo, S. E., & Rasmussen, B. B. (2008) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-149 · Cited by 45
CGI-58/ABHD5-Derived Signaling Lipids Regulate Systemic Inflammation and Insulin Action
Lord, C. C., Betters, J. L., Ivanova, P. T., Milne, S. B., Myers, D. S., Madenspacher, J., Thomas, G., Chung, S., Liu, M., Davis, M. A., et al. (2012) · Diabetes · doi:10.2337/db11-0994 · Cited by 45
“mammalian target of rapamycin (mTOR) (26,27), and JNK (28), which dampen insulin signaling by phosphorylating serine residues of insulin receptor substrate (IRS) proteins (IRS-1 and IRS-2).”
BackgroundInfluentialSelf-citationWang, G., Chen, L., Qin, S., Zhang, T., Yao, J., Yi, Y., & Deng, L. (2022) · Advances in Nutrition · doi:10.1093/advances/nmac055 · Cited by 47
Han, C., Wei, S., He, F., Liu, D., Wan, H., Liu, H., Li, L., Xu, H., Du, X., & Xu, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0098759 · Cited by 49
“Um et al.[26] reported that mice deficient in S6K1, a downstream target of mTOR, increased their in vivo fatty acid oxidation capacity in association with elevated mRNA levels of genes involved in fatty acid oxidation (CPT1 and PPARγ) in skeletal muscle and adipose tissue.”
BackgroundReprogramming of the MicroRNA Transcriptome Mediates Resistance to Rapamycin
Totary-Jain, H., Sanoudou, D., Ben‐Dov, I. Z., Dautriche, C. N., Guarnieri, P., Marx, S. O., Tuschl, T., & Marks, A. R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.416446 · Cited by 48
“Because S6K1 normally suppresses the PI3K/Akt pathway (44, 45), inhibition of S6K1 by rapamycin resulted in increased phosphorylation of Akt and consequently GSK (Fig.”
BackgroundGao, Z., Yin, J., Zhang, J., He, Q., McGuinness, O. P., & Ye, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.007260 · Cited by 47
Aberrant REDD1-mTORC1 responses to insulin in skeletal muscle from Type 2 diabetics
Williamson, D. L., Dungan, C. M., Mahmoud, A. M., Mey, J. T., Blackburn, B. K., & Haus, J. M. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00285.2015 · Cited by 38
“Glucose uptake into tissues upon insulin binding to the insulin receptor, GLUT4 translocation to the plasma membrane is promoted through IRS-1-mediated PI3-kinase activation of Akt, and subsequently the Akt substrate of 160 kDa (AS160) and ubiquitin-specific peptide 6 (Trc-2)/budding uninhibited by benzimidazole/cell…”
BackgroundInfluentialSharma, S., Mathre, S., Visvanathan, R., Shinde, D. D., & Raghu, P. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.084 · Cited by 50
“Thus, a loss of TORC1-mediated feedback control on insulin receptor signaling, as demonstrated to occur in mammalian cells (Gual et al., 2005; Haruta et al., 2000; O’Reilly et al., 2006; Tremblay et al., 2007; Um et al., 2004), may be the underlying reason for increased PIP3 levels in dPIP4K29.”
BackgroundSasaki, C. Y., Chen, G., Munk, R. B., Eitan, E., Martindale, J. L., Longo, D. L., & Ghosh, P. (2015) · European Journal of Immunology · doi:10.1002/eji.201445422 · Cited by 48
Regulation of mRNA Translation as a Conserved Mechanism of Longevity Control
Mehta, R., Chandler-Brown, D., Ramos, F. J., Shamieh, L. S., & Kaeberlein, M. (2010) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-7002-2_2 · Cited by 44
From growing to secreting: New roles for mTOR in aging cells
Pani, G. (2011) · Cell Cycle · doi:10.4161/cc.10.15.16886 · Cited by 43
Tissue-specific mechanisms of fat metabolism that focus on insulin actions
Wu, S., Tan, J., Zhang, H., Hou, D., & He, J. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.12.009 · Cited by 46
“HFD can lead to obesity with insulin resistance through the mTOR/S6 kinase 1 (S6K1) signaling pathway, and S6K1-deficient mice demonstrate improved insulin sensitivity through a negative response to insulin receptor substrate 1 (INSRS1) [69].”
BackgroundLipid droplets, autophagy, and ageing: A cell-specific tale
Maestri, A., Garagnani, P., Pedrelli, M., Hagberg, C. E., Parini, P., & Ehrenborg, E. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102194 · Cited by 48
“…are A. Maestri et al. reduced in ageing (L ¨ onnqvist et al., 1990; Ryd ´ en et al., 2020), concomitantly with a reduction in mitochondrial FA oxidation capacity, which, if upregulated, can increase lifespan and support longevity (Ramachandran et al., 2019; Um et al., 2004; Xu et al., 2012)).”
Wu, S., Bi, J., Cloughesy, T. F., Cavenee, W. K., & Mischel, P. S. (2014) · PubMed Central · doi:10.7497/j.issn.2095-3941.2014.04.004 · Cited by 50
Romanino, K., Mazelin, L., Albert, V., Conjard-Duplany, A., Lin, S., Bentzinger, C. F., Handschin, C., Puigserver, P., Zorzato, F., Schaeffer, L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111448109 · Cited by 43
“Moreover, both mTOR and RAmKOmice show a striking increase in the phosphorylation of PKB/Akt at threonine 308 and serine 473; this increase most likely is based on the lack of feedback inhibition onto insulin receptor substrate 1 by S6 kinase (5).”
BackgroundmTOR-dependent Modulation of Gastric Nesfatin-1/NUCB2
Li, Z., Xu, G., Li, Y., Zhao, J., Mulholland, M. W., & Zhang, W. (2012) · Cellular Physiology and Biochemistry · doi:10.1159/000338503 · Cited by 44
Liu, C., Rajapakse, A. G., Riedo, E., Fellay, B., Bernhard, M. W. S., Montani, J., Yang, Z., & Ming, X. (2016) · Scientific Reports · doi:10.1038/srep20405 · Cited by 48
Kudo, M., Yoshitomi, H., Momoo, M., Suguro, S., Yamagishi, Y., & Gao, M. (2017) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b16-01002 · Cited by 48
Plant miR171 modulates mTOR pathway in HEK293 cells by targeting GNA12
Gismondi, A., Nanni, V., Monteleone, V., Colao, C., Marco, G. D., & Canini, A. (2021) · Molecular Biology Reports · doi:10.1007/s11033-020-06070-6 · Cited by 45
Bhat, N., Narayanan, A., Fathzadeh, M., Kahn, M., Zhang, D., Goedeke, L., Neogi, A., CARDONE, R. L., Kibbey, R. G., Fernandez-Hernando, C. F., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci153724 · Cited by 44
“The mTORC1 activation may, however, contribute to IR in Dyrk1bAAV-WT mice (15, 14) and complement the effect of DAG-induced IRK inhibition.”
Inactivation of hypothalamic FAS protects mice from diet-induced obesity and inflammation
Chakravarthy, M. V., Zhu, Y., Li, Y., Coleman, T., Pappan, K. L., Marshall, C. A., McDaniel, M. L., & Semenkovich, C. F. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800379-jlr200 · Cited by 46
The role of mTOR in lipid homeostasis and diabetes progression
Chakrabarti, P., & Kandror, K. V. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000187 · Cited by 45
“The adipogenic signaling outputs from mTORC1 are transmitted via both S6K1 and 4E-BP1 and 4E-BP2 as S6K1 knockout mice display decreased [63] whereas 4E-BP1 and 4E-BP2 double knockout mice show increased [64] adiposity.”
BackgroundProtein translation paradox: Implications in translational regulation of aging
Kim, H. S., & Pickering, A. M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1129281 · Cited by 46
“Moreover, downregulating S6K signaling to attenuate protein translation in mice improved the locomotor activity, increased the population of naïve T cells, enhanced the bone volume and density, and protected against age- and diet-induced obesity/diabetes by improving insulin sensitivity and reducing adiposity (Um et a…”
BackgroundBranched-Chain Amino Acids in Liver Diseases: Complexity and Controversy
Zhang, Y., Zhan, L., Zhang, L., Shi, Q., & Li, L. (2024) · Nutrients · doi:10.3390/nu16121875 · Cited by 53
“Upon activation, mTORC1 and S6K directly phosphorylate IRS-1 to induce its degradation and alter its localization [35,36], thereby dampening PI3K/Akt activation and ultimately negatively regulating growth factor signaling.”
BackgroundBrimelow, R. E., West, N. P., Williams, L. T., Cripps, A. W., & Cox, A. J. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2014.995264 · Cited by 49
Levels of p27 Sensitize to Dual PI3K/mTOR Inhibition
Lee, M., Theodoropoulou, M., Graw, J., Roncaroli, F., Zatelli, M. C., & Pellegata, N. S. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0188 · Cited by 45
“org Mol Cancer Ther; 10(8) August 2011 1455”
BackgroundInfluentialDrake, J. C., Alway, S. E., Hollander, J. M., & Williamson, D. L. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00337.2010 · Cited by 42
“While acute increases in mTOR promote muscle growth and hypertrophy, chronically high activation of mTOR, as in obese muscle (27, 36, 60), may attenuate muscle growth (56, 57).”
BackgroundResultInfluentialBermúdez‐Silva, F. J., Romero‐Zerbo, S., Haissaguerre, M., Ruz‐Maldonado, I., Lhamyani, S., Bekay, R. E., Tabarin, A., Marsicano, G., & Cota, D. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.020750 · Cited by 43
“Conversely, mice deficient for p70S6K1 (S6K1−/−) are characterized by the lack of the p70S6K1dependent negative feedback on IRS1/2, leading to enhanced insulin sensitivity and normal glucose levels in diet-induced obesity (Um et al., 2004).”
BackgroundMethodWilhelm, A., Lopez-Garcia, L. A., Busschots, K., Fröhner, W., Maurer, F., Boettcher, S., Zhang, H., Schulze, J. O., Biondi, R. M., & Engel, M. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3010477 · Cited by 51
Hirase, C., Maeda, Y., Takai, S., & Kanamaru, A. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.07.023 · Cited by 44
Marfè, G., Stefano, C. D., Gambacurta, A., Ottone, T., Martini, V., Abruzzese, E., Mologni, L., Vallebona, P. S., de Fabritiis, P., Gambacorti-Passerini, C. B., et al. (2011) · Experimental Hematology · doi:10.1016/j.exphem.2011.02.013 · Cited by 45
“Furthermore, a recent study has emphasized the importance of dysregulated translation in a wide range of human malignancies and has also emphasized the important role ofmTOR and its effectors in oncogenesis [14–16].”
BackgroundJacinto, E. (2008) · IUBMB Life · doi:10.1002/iub.56 · Cited by 43
Branched chain amino acids and metabolic regulation
Wang, C., & Guo, F. (2013) · Chinese Science Bulletin · doi:10.1007/s11434-013-5681-x · Cited by 47
Gurriarán‐Rodríguez, U., Santos‐Zas, I., González‐Sánchez, J., Beiroa, D., Moresi, V., Mosteiro, C. S., Lin, W., Viñuela, J. E., Señarís, J., García‐Caballero, T., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2015.40 · Cited by 46
Mammalian Target of Rapamycin and Diabetes: What Does the Current Evidence Tell Us?
Vodenik, B., Rovira, J., & Campistol, J. M. (2009) · Transplantation Proceedings · doi:10.1016/j.transproceed.2009.06.159 · Cited by 45
Shi, J. P., Finckenberg, P., Martonen, E., Ahlroos-Lehmus, A., Pilvi, T. K., Korpela, R., & Mervaala, E. M. A. (2011) · Journal of Functional Foods · doi:10.1016/j.jff.2011.08.001 · Cited by 44
Signaling Pathways Regulating Vascular Smooth Muscle Cell Differentiation
Rzucidlo, E. M. (2009) · Vascular · doi:10.2310/6670.2008.00089 · Cited by 44
“This inhibitory phosphorylation promotes IRS-1 degradation, thereby diminishing insulin or IGF-I signaling,(44,45) and has been implicated in insulin resistance in type 2 diabetes and obesity (see Figure 3).(37,46) The most surprising finding of our study was that rapamycin specifically activated the Akt2 isoform but…”
Background
Metadata
- Authors
- Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J., & Thomas, G.
- Affiliations
- Friedrich Miescher Institute (CH)
- Centre National de la Recherche Scientifique (FR)
- Novartis (Switzerland) (CH)
- Corresponding author
- Thomas, George
- ORCID
- Venue
- Nature
- Published
- 2004-08-11
- Volume
- 431
- Issue
- 7005
- Pages
- 200-205
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2107674876
- Cited by
- 1,677
- References
- 58
- Citations by year
- 2026: 29 · 2025: 30 · 2024: 36 · 2023: 53 · 2022: 57 · 2021: 68 · 2020: 59 · 2019: 56 · 2018: 74 · 2017: 71 · 2016: 84 · 2015: 99 · 2014: 86 · 2013: 101 · 2012: 134
- FWCI
- 25.05
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- S6K1, mTOR signaling, insulin sensitivity, insulin resistance, obesity, high-fat diet, fatty acid beta-oxidation, IRS-1 phosphorylation, beta-cell mass, impaired glucose tolerance, ob/ob mice, leptin deficiency
- MeSH terms
- Aging, Animals, Blood Glucose, Dietary Fats, Enzyme Activation, Fasting, Fatty Acids, Nonesterified, Insulin, Insulin Resistance, Lipolysis, Male, Mice, Inbred C57BL, Obesity, Oxidation-Reduction, Phosphoproteins, Phosphorylation, Receptor, Insulin, RNA, Messenger, Signal Transduction, Gene Deletion, Adipocytes, Mice, Knockout, Ribosomal Protein S6 Kinases, 70-kDa, Mice, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.